Skip to main content
2025 Summer Scientific Forum Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Beata Sweryda-Krawiec, PhD

Associate Director
Boehringer Ingelheim

Beata Sweryda-Krawiec, Ph.D. is an Analytical Scientist at Boehringer Ingelheim, where she leads analytical strategies for small molecules and drug conjugates from early development through clinical stages. She brings over 20 years of pharmaceutical R&D experience, including leadership roles at ImmunoGen, Tarveda Therapeutics, Cerulean Pharma, Amgen, and Novartis.
Beata has deep expertise in analytical method development, impurity characterization, solid-state form selection, and regulatory submissions. She has contributed to multiple INDs and BLAs, with a strong track record in managing complex projects involving highly potent APIs, ADCs, peptide conjugates, and nanoparticle-based delivery systems. At Tarveda, she led formulation development through Phase 3 readiness and commercial DS scale-up. At ImmunoGen, she directed analytical development for ADCs programs and contributed to BLA activities.
Known for her collaborative approach, Beata has successfully led external partnerships with CDMOs and introduced non-traditional CMC strategies to streamline development. She is also a member of the AAPS Scientific Programming Committee and a strong advocate for advancing analytical science in support of innovative therapies.

Disclosure information not submitted.

Presentation(s):